ORDER REMANDING CASE TO STATE COURT AND GRANTING PLAINTIFFS’ REQUEST FOR FEES AND COSTS
INTRODUCTION
This class action suit, originally filed in the San Francisco Superior Court, was removed by defendant Pfizer on the basis of diversity of citizenship. 1 Plaintiffs have filed a motion to remand the case to state court and to recover from defendants their attorneys’ fees and costs stemming from the removal to federal court. Defendant Pfizer filed an opposition, in which all defendants have joined. Plaintiffs’ motion requires the Court to determine whether defendants have met their burden of demonstrating that the amount in controversy, exclusive of interest аnd costs, exceeds $75,000, and if not, whether the removal justifies charging defendants with plaintiffs’ reasonable fees and costs incurred in obtaining remand.
BACKGROUND
Defendants manufacture and sell over-the-counter head lice remedies. Plaintiffs allege that defendants have cоntinued to sell those products despite knowledge that head lice have developed resistance to their active ingredients, rendering the products useless. Plaintiffs seek to represent a class of all California residents who have purchased the allegedly offending products, and for whom the products failed to work. Plaintiffs’ claims are all based on California law; they seek actual damages, punitive damages, injunctive relief and attorneys’ fees.
*1129 DISCUSSION
I. Legal Standard
When a ease is removed from state court, a district court must remand the case if it determines that it lacks subject matter jurisdiction.
See
28 U.S.C. § 1447(c). There is a “strong presumption” against removal jurisdiction,
Gaus v. Miles, Inc.,
When the assertion of subject matter jurisdiction is based on diversity of citizenship, defendants must prove: (1) that all plaintiffs are of different citizenship than all defendants,
Carden v. Arkoma Associates,
II. Analysis
A. Diversity of Citizenship
Defendants have failed to meet their burden of proving that the parties are of diverse citizenship. In the Notice of Removal, defendants allege sufficient facts to prove that plaintiffs are California citizens and that defendant Pfizer is a corporate citizen of Delaware and New York. Citing plaintiffs’ complaint, the Notice asserts, without supporting facts, that “[n]one of the other defendants is a citizen of the State of California.” Notice at ¶ 4. Plaintiffs’ comрlaint, however, does not contain sufficient factual allegations to determine the citizenship of any of the three remaining defendants.
See
Complaint at ¶ 7 (alleging state of incorporation and principal executive offices, but not principal plаce of business, of defendant Warner-Lambert), ¶ 9 (alleging headquarters of defendant Care Technologies, but neither its state of incorporation nor principal place of business), ¶ 10 (alleging headquarters of defendant Hogil Pharmaceutical, but neither its statе of incorporation nor principal place of business). Because a “sufficient factual basis for jurisdiction” appears neither in the complaint nor in the Notice of Removal, removal is improper.
Schroeder,
B. Amount in Controversy
Because it is possible that defendants сould cure these defects and attempt to remove a second time, the Court moves on to their contention that the amount in controversy requirement has been met. On that score, defendants do not dispute that the actual monetary damages to each class member are between $9.00 and $17.00— the approximate cost of a single package of one of the defendants’ products. Instead they make three separate arguments that will be addressed in turn: (1) that compli- *1130 anee with the injunctive relief requеsted by plaintiffs will cost each defendant more than $75,000; (2) that the class members have a common and undivided interest in their claims for punitive damages; and (3) that the value of the claim for attorneys’ fees under the California Consumer Legal Remedies Act (“CLRA”) exceeds $75,000 рer named plaintiff.
1. Cost of Compliance with Injunc-tive Relief
Defendants point out that plaintiffs have requested an injunction that would prohibit defendants from selling the products at issue.
See
Complaint, Prayer for Relief at p. 18. Defendants have submitted evidence that the cost to each defendant of comрlying with such an injunction would exceed $75,000. Relying on a recent Seventh Circuit case,
In re Brand Name Prescription Drugs Antitrust Litigation, (“Brand Name”),
Defendants’ argument neglects, indeed obfuscates, the fact that the Ninth Circuit rejected the “defendant’s-viewpoint” approach in
Snow v. Ford Motor Co.,
“Th[at] argument misses the mark. Given Snyder[ v. Harris,394 U.S. 332 ,89 S.Ct. 1053 ,22 L.Ed.2d 319 (1969) ], the рroper focus in this case is not influenced by the type of relief requested, but rather continues to depend upon the nature and value of the right asserted. The right asserted by plaintiffs is the right of individual future consumers to be protected from Ford’s allegedly deceptive advertising which is said to injure them in the amount of $11.00 each. That figure is below the jurisdictional minimum.”
Snow, supra at 790-791 (citations omitted, footnote omitted).
Snow is squarely on point. The right asserted by plaintiffs in this case is the right of individual future consumers to be protected from purchasing defendants’ allegedly defective products. Such a purсhase is said to injure consumers in an amount between $9.00 and $17.00 each. Defendants’ attempt to distinguish Snow on its facts is unpersuasive and contrary to the very specific holding in Snow. Defendants argue that, in Snow, if any one class member obtained an injunction, “the cost to the defendant would have been $11 — the vаlue of the wiring connector kit [at issue].” Defendants’ Opposition at 8. 2 This argument lacks merit. Even if it were accurate,- defendants’ argument “misses the mark.” 3 It erroneously views the value of the injunction sought in the Snow case from the defendant’s viewpoint — an approach Snoiu squarely rejected.
*1131 2. Aggregation of Punitive Damages
Defendants’ next contention is that the members of the class have а common and undivided interest in their claims for punitive damages; therefore, the punitive damages claims may be aggregated to satisfy the jurisdictional minimum. Although that argument has not been addressed by the Ninth Circuit, it has been repeatedly rejected by district courts in this circuit, including thе undersigned, as inconsistent with Ninth Circuit precedent.
See, e.g., Gibson v. Chrysler Corp.,
“The Ninth Circuit has held that claims are only common and undivided if they derive from rights that plaintiffs hold in group status, or they relate to a single res such as an estate or an insurance policy.
Eagle v. AT & T Co.,
Defendants have cited
In re Northern Dist. of Cal., Daikon Shield IUD Prod. Liab. Litig.,
Aggregation of punitive damages to meet the jurisdictional minimum is not permitted in this circuit.
3. Attribution of Attorneys’ Fees and Supplemental Jurisdiction
Defendants’ final argument regarding the jurisdictional amount progresses as follows: (1) plaintiffs have a claim for attorneys’ fees which is likely to exceed $150,000; (2) those fees are properly attributed solely to the two named plaintiffs, not absent class members, which raises the amount in controversy for 'the named plaintiffs beyond the jurisdictional minimum;' and (3) because the Court has jurisdiction over the claims of the named plaintiffs, it may exercise supplemental jurisdiction over the claims of the remaining class members. That argument fails.
Defendants present no evidence that the attorneys’ fees will actually exceed $150,000, as is their burden. They rely only оn plaintiffs’ admission that this assumption is a reasonable one. See Defendants’ Opposition at 14; Plaintiffs’ Memorandum at 4. Such reliance is inappropriate; plaintiffs may not concede subject matter jurisdiction.
Even if defendants’ assumption is reasonable, the assertiоn of jurisdiction on this basis still fails. It is based on the presumption that
Zahn v. International Paper Co.,
*1132
The Court finds persuasive the opinions of the Third and Tenth Cirсuits which concluded that section 1367 did not overrule
Zahn, see Meritcare Inc. v. St. Paul Mercury Ins. Co.,
Accordingly, the teaching of
Goldberg
applies with full force—attorneys’ fees may neither be attributed solely to the named plaintiffs nor treated as an undivided common fund to satisfy the jurisdictional minimum.
Goldberg,
4. Certification to the Ninth Circuit
Defendants point out that the Ninth Circuit has not ruled on many of these issues, and that an order remanding this action would not be appealable, 28 U.S.C. § 1447(d). Because the circuits have split on these issues, defendants’ request that the Court deny remand on this basis alone and certify the order to the Ninth Circuit for review.
This the Court cannot dо. If the Court is without jurisdiction, it must remand.
See
28 U.S.C. § 1447(c). Furthermore, because of the “strong presumption” against removal jurisdiction, all doubts must be resolved in favor of remand.
See Gaus,
5. Attorneys’ Fees and Costs
Plaintiffs have requested that thе Court order defendants to pay the attorneys’ fees and costs plaintiffs incurred in connection with the removal of this action. The Court may, in its discretion, issue such an order under 28 U.S.C. section 1447(c); no finding of bad faith is required.
See Moore v. Permanente Medical Group, Inc.,
When last considering this issue in 1996, the undersigned declined to award fees and costs because the law regarding removal of this kind of case was “not entirely clear.”
Villarreal,
CONCLUSION
Because defendants have failed to carry their burden of showing that there is federal subject matter jurisdiction over this matter, it is REMANDED to the San Francisco Superior Court. Plaintiffs’ request, under 28 U.S.C. section 1447(c), for attorneys’ fees and expenses incurred as a result оf the removal is GRANTED. Plaintiffs are ORDERED to submit, within seven days of this order, proof of those fees and expenses together with a proposed order. Defendants SHALL then have one week to object to the reasonableness of the fees and costs.
SO ORDERED.
Notes
. All defendants joined the removal.
. Although the opрosition brief was filed by defendant Pfizer, it was joined, and thereby endorsed, by all defendants. Accordingly, the Court treats it as a paper filed by all defendants.
. The cost to Ford of a single injunction would not have been $11.00. Mr. Snow sought "to enjoin Ford from continuing to sell the irailering spеcial packages without a wiring connector kit.” Snow, supra at 788. The Ninth Circuit observed that the injunction would have cost Ford more than $10,000 because a single injunction "would affect all of Ford's future trailer package sales to thousands of other individual consumers.” Id. at 790. That is precisely the argument made by defendants in the case at bar.
